Myaderm offering is now closed and is no longer accepting investments.

INVEST IN MYADERM TODAY!

Revolutionizing Pain Relief & Skin Care with CBD

Myaderm is revolutionizing how you look and feel. The revolution started in 2017 with innovative cannabidiol (CBD) products that deliver effective results. Today, as a leading brand distributed coast to coast, we continue our commitment to dramatically improve how you look and feel.

This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Myaderm

$42,998.04 Raised

REASONS TO INVEST

Reasons Icon

Over three years sold coast to coast through national retailers like GNC, Rite Aid, Dick’s Sporting Goods, Golf Galaxy, 7-Eleven.

Reasons Icon

Myaderm is the only CBD brand sold through national retailers that is FDA compliant.

Reasons Icon

The US skin care market size is $18 billion and the US topical pain relief market size is $3 billion.*

*Market statistics provided by Statista (sourcesource)

Revolutionizing how you look and feel

Myaderm formulates, develops, manufactures, and sells skin care and pain relief products that utilize CBD as a key ingredient. We sell our products through national and local retailers, as well as directly to customers through our website. We provide products with proven pharmaceutical technologies that deliver results


We are committed to providing the most compelling value in the market with minimized or no price friction for customers. Our mission is to revolutionize how people look and feel through the latest innovations in ingredients and technologies.


The Problem


CBD products that have low concentrations and lack technologies don’t deliver 

There is a significant amount of confusion and misinformation about topical CBD products. The primary problem is with brands that rely on other well known ingredients (e.g. menthol, lidocaine) to get an effect. Those topical products also have incredibly low concentrations of CBD and lack any capable technologies (e.g. transdermal delivery, emulsification) that allow CBD to deliver results.


The Solution


Myaderm uses CBD and pharmaceutical technologies for fast acting relief and clear results


Pain Relief Competitive Advantages:

  • Transdermal: drives CBD into muscle and connective tissue.
  • Non-greasy and fast absorbing: other brands use oil-bases to hold CBD.
  • Emulsification: high concentration of CBD in a water-bases.
  • In-house formulation and manufacturing: does not utilize contract manufacturers with stock formulas.



Skin Care Competitive Advantages:

  • Gel-Cream technology that is non-greasy and fast absorbing: other brands use oil-bases to hold CBD.
  • Key Ingredients paired with CBD: Hyaluronic Acid, Pro-Retinol.
  • Emulsification: high concentration of CBD in a water-bases.
  • In-house formulation and manufacturing: does not utilize contract manufacturers with stock formulas.



INNOVATIVE

Industry leading IP and pharmaceutical technologies utilized in all products. We do not use contract manufacturers with stock formulas.


SCALABLE

Cost reduction and quality control with internal manufacturing and fulfillment expertise. We manufacture and formulate all products.


GLOBAL

FDA compliant and therapeutic products create rapid and sustainable sales.

The Market


The only CBD brand sold through national retailers that is FDA compliant

(source)


Skin care, as a market segment, is growing faster than any other part of the beauty industry. Sales of skincare products grew by 13% last year in the United States, while makeup grew by only 1% in the same period. Online beauty retailers grew 24% in that time, with skincare leading the way. (source)



Within the topical pain relief category, the rising incidences of arthritis, joint pain, and diabetic neuropathy is driving the industry growth. The growing geriatric population in the US is providing further impetus to the industry. Fewer side effects induced by topical pain relief related to oral medicine is driving the industry forward. Greater accessibility and growing awareness of topical pain medications are further aiding the industry growth.


(source)

Our Traction


Nationally distributed & selling online

Myaderm has succeeded at the national level with coast to coast sales through national retailers like GNC, Rite Aid, Dick’s Sporting Goods, Golf Galaxy, 7-Eleven.


*This testimonial may not be representative of the experience of other customers and is not a guarantee of future performance or success.


Why Invest


Welcome to revolution in pain relief and skin care

We are dedicated to being leaders in the skin care and pain relief markets to revolutionize how people look and feel.



Code View

ABOUT

HEADQUARTERS

9200 E. Mineral Avenue, Ste. 355
Centennial, CO 80112
VALUATION

$24.88M

Myaderm is revolutionizing how you look and feel. The revolution started in 2017 with innovative cannabidiol (CBD) products that deliver effective results. Today, as a leading brand distributed coast to coast, we continue our commitment to dramatically improve how you look and feel.

TEAM

Eric Smart
Eric Smart
Chief Executive Officer

•CEO of a contract food manufacturer

•Managing Partner of an industrial automation firm that ran projects for Teva Pharmaceuticals, Edwards Lifesciences and Dean Foods

•BA from The Citadel in Charleston, SC

•MBA from The University of California, Irvine

Mark Abdou

Mark Abdou

Chief Legal Officer

•Managing Partner of a law firm

•Specialization in corporate securities and finance for private and public companies 

•BA from The University of Southern California

•JD from The University of California, Berkley

Karen Chin

Karen Chin

Vice President of Brand Creative

•Director of a design agency

•Brand consultant for Hanes, Celestial Seasonings and other beauty and natural food brands

•Adjunct faculty for Rocky Mountain College of Art and Design

•BA from Rhode Island School of Design

Gerrad Bruce

Gerrad Bruce

Vice President of Operations

•Vice President of Operations for Duke Foods 

•Private label manufacturing for Sam’s Club, HEB and Publix

•SQF certification and audit experience

•BS from Clemson University

•MBA from Clemson University

TERMS

Myaderm
Overview
PRICE PER SHARE
$2
DEADLINE
Sep 16, 2022
VALUATION
$24.88M
AMOUNT RAISED
$42,998.04
Breakdown
MIN INVESTMENT
$250.00
MAX INVESTMENT
$1,069,998.00
MIN NUMBER OF SHARES OFFERED
5,000
OFFERING TYPE
Equity
ASSET TYPE
COMMON
SHARES OFFERED
Common Stock
MAX NUMBER OF SHARES OFFERED
534,999

Maximum Number of Shares Offered subject to adjustment for bonus shares


Company

:

Myaderm, Inc.

Corporate Address

:

9200 E. Mineral Avenue, Ste. 355, Centennial, CO 80112

Offering Minimum

:

$10,000.00

Offering Maximum

:

$1,069,998.00

Minimum Investment Amount

(per investor)

:

$250.00











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

5,000

Maximum Number of Shares Offered

:

534,999

Price per Share

:

$2.00

Pre-Money Valuation

:

$24,883,884.00











Voting Rights of Securities Sold in this Offering

Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.


*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.

Investment Incentives*

Time-Based:

Early Bird

Invest within the first two weeks and receive an additional 10% bonus shares.

Amount-Based

$250+
Advanced Therapy Fast Acting Relief Cream 1.7oz. ($49.99 retail value)

$500+
Advanced RX Fast Acting Relief Cream RX10 1.7oz. ($79.99 retail value)

$1,000+
3 Advanced RX Fast Acting Relief Cream RX20 1.7oz. ($299.97 retail value) 

$2,000+
3 Advanced RX Fast Acting Relief Cream RX20 1.7oz., 1 Ultimate Hydration Facial Moisturizer 1.7oz., 1 Ultimate Calming Cream 1.7oz and 1 Ultimate Wrinkle Repair 1.7oz. Set. ($374.94 retail value)

$5,000+

10 Products of choice (up to $999.99 retail value)

$10,000+

20 Products of choice (up to $1,999.80 retail value)

*All perks occur when the offering is completed.

The 10% StartEngine OWNers' Bonus

Myaderm will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $2.00 / share, you will receive 110 shares of Common Stock, meaning you'll own 110 shares for $200. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus.

ALL UPDATES

09.15.22

Only 12 Hours Left to Invest!

There are only 12 Hours Left to Invest!

 

Counting down the last 12 Hours until this offering closes on StartEngine!

 

We’re looking forward to sharing our next goals with you, so please make sure you join our mailing list. Sign Up!

 

You can still invest today (Thursday, September 15, 2022) but it must be before 11:59 PM PST (tonight).

09.14.22

Only 24 Hours Left to Invest!

There is Only 1 day Left to Invest!

 

Counting down the last 24 hours until our current offering closes on StartEngine!

 

We have some exciting plans moving forward, so make sure you join our mailing list for updates.

 

You can still invest before Thursday September 15th at 11:59 PM PST


09.13.22

48 Hours Until Our Campaign Closes!

Thank you for your support and belief!

 

We’re committed to building the future of skin care and pain relief using cannabidiol (CBD) as a key ingredient.

 

If you love an active lifestyle and great skin like us, and believe in the innovation and excitement of transdermal CBD, then we are the investment for you!

09.12.22

Join Our Webinar on Wednesday September 14th to Hear CEO and Founder, Eric Smart Speak

On Wednesday September 14th at 2pm EST, Myaderm will be hosting a webinar

 

Hello current and future investors,

Please join this webinar to hear from CEO and Founder, Eric Smart as he gives company updates before our campaign ends on Thursday September 15th. Find out how Myaderm is building the most successful brand using CBD as a key ingredient. He’ll answer any questions you may have about investing and share all the exciting things happening at Myaderm.

You should take advantage of this FREE webinar to find out how to invest, before Myaderm goes public. 

You can register for the webinar on Zoom here. Passcode: 1234

We encourage everyone to spread the word and about this online event.

09.08.22

Only 1 Week Left for our StartEngine Campaign!

Our campaign on StartEngine will officially close in 7 days. So, click the green Invest Now button at the top right-hand side of the page today! And once again, to all our investors who have helped get us this far. THANK YOU

 

Myaderm manufactures and distributes effective skin care and pain relief products using cannabidiol (CBD) as a key ingredient. Myaderm manufactures the only nationally sold FDA-compliant portfolio of CBD products and all products contain pure CBD (no THC) from American industrial hemp sources.


09.06.22

Only 9 Days Left to Invest!


We’re getting close to completing our current offering, and there are now only 9 days left until the offering closes on StartEngine!

We want to thank you for your support. Together we will revolutionize the way you look and feel.

If you are still considering investing or upping your current investment in Myaderm, today is the day!


09.01.22

Only Two Weeks Left to Invest in Myaderm on StartEngine!

We’re on-the-clock for counting down to the offer closing date of September 15, 2022.

 

Join our investor family, have confidence in how we are revolutionizing the way you look and feel, manufacturing and distributing effective skin care and pain relief products using cannabidiol (CBD) as a key ingredient. Myaderm manufactures the only nationally sold FDA-compliant portfolio of CBD products and all products contain pure CBD (no THC) from American industrial hemp sources.

 

Right now is the perfect time for you to make your best decision of the day (if not the week, month and year!) You are here at our StartEngine investment page reading this update, just scroll up to the top and hit Invest Now. Questions? We have answers. Share them with us in the comments section.


08.24.22

Reminder: Join Us for Our Investor Event with CEO and Founder, Eric Smart


On Thursday August 25th at 1pm EST, Myaderm will be hosting a webinar

Hello current and future investors,

This event is an exclusive opportunity to hear from CEO and Founder, Eric Smart as he gives company updates and speaks to our UPCOMING marketing efforts. Find out how Myaderm is building the most successful brand using CBD as a key ingredient. He’ll answer any questions you may have about investing and share all the exciting things happening at Myaderm.

You should take advantage of this FREE webinar to find out how to invest, before Myaderm goes public. 

You can register for the webinar on Zoom here. Passcode: 1234

We encourage everyone to spread the word and about this online event.

08.22.22

Join Us for Our Investor Event with CEO and Founder, Eric Smart

On Thursday August 25th at 1pm EST, Myaderm will be hosting a webinar

 

Hello current and future investors,

This event is an exclusive opportunity to hear from CEO and Founder, Eric Smart as he gives company updates and speaks to our UPCOMING marketing efforts. Find out how Myaderm is building the most successful brand using CBD as a key ingredient. He’ll answer any questions you may have about investing and share all the exciting things happening at Myaderm.

You should take advantage of this FREE webinar to find out how to invest, before Myaderm goes public. 

You can register for the webinar on Zoom here. Passcode: 1234

We encourage everyone to spread the word and about this online event.

07.27.22

Join Our Webinar Today 1pm EST to Find Out More About Going Public

Owners bonus
Stack Owner's Bonus & Rewards!

Members get an extra 10% shares in addition to rewards below!

REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign perk. Get rewarded for investing more into Myaderm.

$250.00

StartEngine Owner’s Bonus

This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

$250.00

$250+

Advanced Therapy Fast Acting Relief Cream 1.7oz. ($49.99 retail value)

$500.00

$500+

Advanced RX Fast Acting Relief Cream RX10 1.7oz. ($79.99 retail value)

$1,000.00

$1,000+

3 Advanced RX Fast Acting Relief Cream RX20 1.7oz. ($299.97 retail value)

$2,000.00

$2000+

3 Advanced RX Fast Acting Relief Cream RX20 1.7oz., 1 Ultimate Hydration Facial Moisturizer 1.7oz., 1 Ultimate Calming Cream 1.7oz and 1 Ultimate Wrinkle Repair 1.7oz. Set. ($374.94 retail value)

$5,000.00

$5,000+

10 Products of choice (up to $999.99 retail value)

$10,000.00

$10,000+

20 Products of choice (up to $1,999.80 retail value)

JOIN THE DISCUSSION













0/2500

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

WHY STARTENGINE?

REWARDS

We want you to succeed and get the most out of your money by offering rewards and memberships!

SECURE

Your info is your info. We take pride in keeping it that way!

DIVERSE INVESTMENTS

Invest in over 200 start-ups and collectibles!

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

RAISED
$42,998.04
INVESTORS
53
MIN INVEST
$250.00
VALUATION
$24.88M

@ 2022 All Rights Reserved

Apple Store Logo

Get To Know Us

Our Team

Careers

Blog

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.


www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.


Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA/SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.


Investment opportunities posted and accessible through the site are of three types:


1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.


Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.


By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.


Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.


California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.


StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.